A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 11,748 shares of ABT stock, worth $1.36 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
11,748
Previous 11,868 1.01%
Holding current value
$1.36 Million
Previous $1.23 Million 8.6%
% of portfolio
0.52%
Previous 0.51%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$100.07 - $118.13 $12,008 - $14,175
-120 Reduced 1.01%
11,748 $1.34 Million
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $136,086 - $151,906
1,351 Added 12.85%
11,868 $1.23 Million
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $36,141 - $39,916
330 Added 3.24%
10,517 $1.2 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $30,303 - $37,094
336 Added 3.41%
10,187 $1.12 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $9,648 - $11,576
101 Added 1.04%
9,851 $954,000
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $29,024 - $32,339
288 Added 3.04%
9,750 $1.06 Million
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $49,786 - $58,601
514 Added 5.74%
9,462 $958,000
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $12,928 - $15,166
136 Added 1.54%
8,948 $982,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $72,473 - $83,910
749 Added 9.29%
8,812 $912,000
Q2 2022

Aug 09, 2022

SELL
$102.07 - $123.37 $1,224 - $1,480
-12 Reduced 0.15%
8,063 $873,000
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $4,446 - $5,422
39 Added 0.49%
8,075 $907,000
Q4 2021

Mar 10, 2022

BUY
$115.53 - $141.46 $928,399 - $1.14 Million
8,036 New
8,036 $983,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.